Clinical Trial Update: Prediction of Hepatitis C Recurrence in Liver Transplant Recipients

View source ↗

Summary

A clinical trial evaluating the prediction of hepatitis C recurrence after liver transplantation was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Northwestern University | Conditions: Complication of Transplanted Liver, Hepatitis C, Chronic | Status: TERMINATED